Organism name | Polysiphonia sphaerocarpa |
---|---|
Genus | Polysiphonia |
Family | Rhodomelaceae |
Kingdom |
Linked NCBI taxonomy name | Polysiphonia |
---|---|
Linked NCBI taxonomy ID | 2804 |
Linked level | genus |
Family in NCBI taxonomy | Rhodomelaceae |
---|---|
ID | 2803 |
Kingdom (Superkingdom) in NCBI taxonomy | Eukaryota |
---|---|
ID | 2759 |
Plant class | |
---|---|
ID |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00033540
![]() |
2,4,6-Tribromophenol
|
C004554
|
9 / 1 |
![]() |
||||
C00036481
![]() |
2-Bromophenol
|
CHEMBL186007
|
C032038
|
2 / 2 / 0 | 7 / 0 | No. 2101 |
![]() |
|
C00036569
![]() |
4-Bromophenol
|
CHEMBL57284
|
C032037
|
2 / 2 / 0 | No. 2101 |
![]() |
||
C00036465
![]() |
2,6-Dibromophenol
|
CHEMBL111507
|
C038964
|
5 / 7 / 2 | 7 / 0 | No. 2101 |
![]() |
|
C00033541
![]() |
2,4-Dibromophenol
|
CHEMBL186858
|
C013930
|
2 / 2 / 0 | 10 / 0 | No. 2101 |
![]() |
|
C00036541
![]() |
3-Bromo-4-hydroxybenzaldehyde
|
No. 3064 |
![]() |
|||||
C00036515
![]() |
3,5-Dibromo-4-hydroxybenzaldehyde
|
CHEMBL254956
|
No. 3064 |
![]() |
||||
C00036459
![]() |
2,4,6-Tribromoanisole
|
No. 5831 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | C00033541 C00036465 C00036481 C00036569 | 2 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00033541 C00036465 C00036481 C00036569 | 0 / 0 |
P18507 | Gamma-aminobutyric acid receptor subunit gamma-2 | GABA-A gamma | C00036465 | 4 / 2 |
P47870 | Gamma-aminobutyric acid receptor subunit beta-2 | GABA-A beta | C00036465 | 0 / 0 |
P14867 | Gamma-aminobutyric acid receptor subunit alpha-1 | GABA-A alpha | C00036465 | 1 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
6770 | STAR, STARD1 | steroidogenic acute regulatory protein |
C00033540
C00033541
C00036465
C00036481
|
3284 | HSD3B2, HSD3B, HSDB, SDR11E2 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 (EC:1.1.1.145 5.3.3.1) |
C00033540
C00033541
C00036465
C00036481
|
1586 | CYP17A1, CPT7, CYP17, P450C17, S17AH | cytochrome P450, family 17, subfamily A, polypeptide 1 (EC:1.14.99.9 4.1.2.30) |
C00033540
C00033541
C00036465
C00036481
|
1583 | CYP11A1, CYP11A, CYPXIA1, P450SCC | cytochrome P450, family 11, subfamily A, polypeptide 1 (EC:1.14.15.6) |
C00033540
C00033541
C00036481
|
3295 | HSD17B4, DBP, MFE-2, MPF-2, PRLTS1, SDR8C1 | hydroxysteroid (17-beta) dehydrogenase 4 (EC:4.2.1.107 4.2.1.119 1.1.1.n12) |
C00033541
C00036465
C00036481
|
1585 | CYP11B2, ALDOS, CPN2, CYP11B, CYP11BL, CYPXIB2, P-450C18, P450C18, P450aldo | cytochrome P450, family 11, subfamily B, polypeptide 2 (EC:1.14.15.4 1.14.15.5) |
C00033540
C00033541
C00036465
|
1588 | CYP19A1, ARO, ARO1, CPV1, CYAR, CYP19, CYPXIX, P-450AROM | cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00033540
C00033541
C00036481
|
3292 | HSD17B1, EDH17B2, EDHB17, HSD17, SDR28C1 | hydroxysteroid (17-beta) dehydrogenase 1 (EC:1.1.1.62) |
C00033541
C00036465
C00036481
|
7276 | TTR, CTS, CTS1, HsT2651, PALB, TBPA | transthyretin |
C00033540
C00033541
|
1589 | CYP21A2, CA21H, CAH1, CPS1, CYP21, CYP21B, P450c21B | cytochrome P450, family 21, subfamily A, polypeptide 2 (EC:1.14.99.10) |
C00033540
C00036465
|
7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00033540
|
3156 | HMGCR, LDLCQ3 | 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) |
C00033541
|
OMIM | preferred title | UniProt |
---|---|---|
#114500 | Colorectal cancer; crc |
P18054
|
#607208 | Dravet syndrome |
P18507
|
#607681 | Epilepsy, childhood absence, susceptibility to, 2; eca2 |
P18507
|
#611136 | Epilepsy, juvenile myoclonic, susceptibility to, 5; ejm5 |
P14867
|
#133239 | Esophageal cancer |
P18054
|
#604233 | Generalized epilepsy with febrile seizures plus, type 1; gefsp1 |
P18507
|
#611277 | Generalized epilepsy with febrile seizures plus, type 3; gefsp3 |
P18507
|